受体阻滞剂-话题@MedSci

#受体阻滞剂#

148篇内容 | 3269人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1995137, encodeId=2199199513eb9, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=JAHA：接受非心脏手术的糖尿病患者到底该怎样服用β受体阻滞剂？, objectType=article, longId=87327, objectId=decf8e3276c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=decf8e3276c, replyNumber=0, likeNumber=76, createdTime=2017-10-10, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=decf8e3276c, moduleTitle=JAHA：接受非心脏手术的糖尿病患者到底该怎样服用β受体阻滞剂？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=decf8e3276c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995147, encodeId=ef25199514e15, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=JACC：心衰患者给予β-受体阻滞剂很大耐受剂量还有改善的空间吗？, objectType=article, longId=100959, objectId=f9bf100959f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9bf100959f3, replyNumber=0, likeNumber=65, createdTime=2017-09-06, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9bf100959f3, moduleTitle=JACC：心衰患者给予β-受体阻滞剂很大耐受剂量还有改善的空间吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9bf100959f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995136, encodeId=791d1995136c3, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=BMJ：α受体阻滞剂治疗输尿管结石，效果怎样？, objectType=article, longId=83427, objectId=22df8342e56, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22df8342e56, replyNumber=0, likeNumber=91, createdTime=2017-06-02, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22df8342e56, moduleTitle=BMJ：α受体阻滞剂治疗输尿管结石，效果怎样？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=22df8342e56)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995140, encodeId=61e3199514029, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=JAMA Intern Med：养老院老年AMI患者处方β-受体阻滞剂有无生存获益？, objectType=article, longId=91992, objectId=e29c919926f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e29c919926f, replyNumber=0, likeNumber=69, createdTime=2018-01-03, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e29c919926f, moduleTitle=JAMA Intern Med：养老院老年AMI患者处方β-受体阻滞剂有无生存获益？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e29c919926f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995135, encodeId=05461995135bf, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=GW-ICC 2016：郭艺芳谈心衰合并COPD，β受体阻滞剂使用率低, objectType=article, longId=80670, objectId=5b74806e02d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b74806e02d, replyNumber=0, likeNumber=126, createdTime=2017-07-25, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b74806e02d, moduleTitle=GW-ICC 2016：郭艺芳谈心衰合并COPD，β受体阻滞剂使用率低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b74806e02d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995131, encodeId=5a3319951319e, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=2016α/β受体阻滞剂在高血压治疗中应用的中国专家共识发布, objectType=article, longId=73740, objectId=f03ee37403a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f03ee37403a, replyNumber=0, likeNumber=29, createdTime=2017-04-18, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f03ee37403a, moduleTitle=2016α/β受体阻滞剂在高血压治疗中应用的中国专家共识发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f03ee37403a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995132, encodeId=fad0199513272, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=BMJ：早期使用β受体阻滞剂可降低急性心肌梗死患者30天死亡率, objectType=article, longId=78051, objectId=3c5fe8051d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c5fe8051d7, replyNumber=0, likeNumber=89, createdTime=2017-08-03, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c5fe8051d7, moduleTitle=BMJ：早期使用β受体阻滞剂可降低急性心肌梗死患者30天死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c5fe8051d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995122, encodeId=d606199512232, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=非心脏手术患者的高血压治疗无需β受体阻滞剂？, objectType=article, longId=57289, objectId=730f5e289eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=730f5e289eb, replyNumber=0, likeNumber=95, createdTime=2016-06-29, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=730f5e289eb, moduleTitle=非心脏手术患者的高血压治疗无需β受体阻滞剂？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=730f5e289eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995125, encodeId=aecb199512568, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=CMAJ：服用α-受体阻滞剂的老人中风风险更高, objectType=article, longId=60393, objectId=89836039354, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89836039354, replyNumber=0, likeNumber=70, createdTime=2016-09-13, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89836039354, moduleTitle=CMAJ：服用α-受体阻滞剂的老人中风风险更高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89836039354)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995123, encodeId=eb301995123d3, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=心衰伴房颤患者，β受体阻滞剂仍是治疗的“基石”吗？, objectType=article, longId=58273, objectId=c697582e312, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c697582e312, replyNumber=0, likeNumber=95, createdTime=2016-07-25, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c697582e312, moduleTitle=心衰伴房颤患者，β受体阻滞剂仍是治疗的“基石”吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c697582e312)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995129, encodeId=746b199512902, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=BMJ：β受体阻滞剂治疗射血分数减少的心衰患者，不受年龄和性别的影响, objectType=article, longId=66915, objectId=de9d66915e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de9d66915e9, replyNumber=0, likeNumber=71, createdTime=2016-08-15, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de9d66915e9, moduleTitle=BMJ：β受体阻滞剂治疗射血分数减少的心衰患者，不受年龄和性别的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de9d66915e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995120, encodeId=cbde199512030, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=JACC：急性心肌梗死后β受体阻滞剂的剂量对生存率的影响, objectType=article, longId=56459, objectId=e57356459ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e57356459ae, replyNumber=0, likeNumber=65, createdTime=2016-04-22, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e57356459ae, moduleTitle=JACC：急性心肌梗死后β受体阻滞剂的剂量对生存率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e57356459ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995130, encodeId=fc8e19951309d, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=Hepatology：非选择性β受体阻滞剂不会肝硬化患者的死亡率, objectType=article, longId=71273, objectId=78ace12730c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78ace12730c, replyNumber=0, likeNumber=66, createdTime=2017-01-23, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78ace12730c, moduleTitle=Hepatology：非选择性β受体阻滞剂不会肝硬化患者的死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78ace12730c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995127, encodeId=ebdc199512e0d, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=CMAJ：α-受体阻滞剂和缺血性卒中，你知多少？, objectType=article, longId=61287, objectId=a0726128e27, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0726128e27, replyNumber=0, likeNumber=76, createdTime=2016-04-15, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0726128e27, moduleTitle=CMAJ：α-受体阻滞剂和缺血性卒中，你知多少？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0726128e27)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995118, encodeId=993a199511834, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=World J Surg：闭合性创伤性脑损伤后，β受体阻滞剂对生存率的影响, objectType=article, longId=54975, objectId=02df549e5eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02df549e5eb, replyNumber=0, likeNumber=68, createdTime=2016-03-13, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02df549e5eb, moduleTitle=World J Surg：闭合性创伤性脑损伤后，β受体阻滞剂对生存率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=02df549e5eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995124, encodeId=367d19951247b, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=Thorax：长效β受体阻滞剂与长效毒蕈碱受体拮抗剂联合治疗COPD的疗效与安全分析, objectType=article, longId=58515, objectId=c3125851569, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3125851569, replyNumber=0, likeNumber=83, createdTime=2016-08-04, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3125851569, moduleTitle=Thorax：长效β受体阻滞剂与长效毒蕈碱受体拮抗剂联合治疗COPD的疗效与安全分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3125851569)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995128, encodeId=4177199512830, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=Chest：治疗脓毒症期间房颤——β受体阻滞剂优于CCBs, objectType=article, longId=61921, objectId=f1336192167, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1336192167, replyNumber=0, likeNumber=0, createdTime=2016-09-26, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1336192167, moduleTitle=Chest：治疗脓毒症期间房颤——β受体阻滞剂优于CCBs, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1336192167)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995126, encodeId=e92f19951263c, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=Sci Rep：终末期肾脏疾病患者可应用β受体阻滞剂预防房颤发生, objectType=article, longId=61258, objectId=b2b761258d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2b761258d2, replyNumber=0, likeNumber=32, createdTime=2016-03-20, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2b761258d2, moduleTitle=Sci Rep：终末期肾脏疾病患者可应用β受体阻滞剂预防房颤发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2b761258d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995121, encodeId=852519951211f, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=JAMA Intern Med：使用β受体阻滞剂降压治疗风险大, objectType=article, longId=57029, objectId=deca5e0298e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=deca5e0298e, replyNumber=0, likeNumber=62, createdTime=2016-07-16, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=deca5e0298e, moduleTitle=JAMA Intern Med：使用β受体阻滞剂降压治疗风险大, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=deca5e0298e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995116, encodeId=d5261995116d0, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=BJA：β-受体阻滞剂对腹主动脉瘤病人体能的影响, objectType=article, longId=53087, objectId=f9315308ecd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9315308ecd, replyNumber=0, likeNumber=69, createdTime=2016-01-09, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9315308ecd, moduleTitle=BJA：β-受体阻滞剂对腹主动脉瘤病人体能的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9315308ecd)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

受体阻滞剂

2020-05-29

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

JAHA：接受非心脏手术的糖尿病患者到底该怎样服用β受体阻滞剂？

2017-10-10

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

JACC：心衰患者给予β-受体阻滞剂很大耐受剂量还有改善的空间吗？

2017-09-06

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

BMJ：α受体阻滞剂治疗输尿管结石，效果怎样？

2017-06-02

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

JAMA Intern Med：养老院老年AMI患者处方β-受体阻滞剂有无生存获益？

2018-01-03

zhaojie88 (审核中...)

前往app查看评论内容

#受体阻滞剂#

GW-ICC 2016：郭艺芳谈心衰合并COPD，β受体阻滞剂使用率低

2017-07-25

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

2016α/β受体阻滞剂在高血压治疗中应用的中国专家共识发布

2017-04-18

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

BMJ：早期使用β受体阻滞剂可降低急性心肌梗死患者30天死亡率

2017-08-03

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

非心脏手术患者的高血压治疗无需β受体阻滞剂？

2016-06-29

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

CMAJ：服用α-受体阻滞剂的老人中风风险更高

2016-09-13

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

心衰伴房颤患者，β受体阻滞剂仍是治疗的“基石”吗？

2016-07-25

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

BMJ：β受体阻滞剂治疗射血分数减少的心衰患者，不受年龄和性别的影响

2016-08-15

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

JACC：急性心肌梗死后β受体阻滞剂的剂量对生存率的影响

2016-04-22

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

Hepatology：非选择性β受体阻滞剂不会肝硬化患者的死亡率

2017-01-23

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

CMAJ：α-受体阻滞剂和缺血性卒中，你知多少？

2016-04-15

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

World J Surg：闭合性创伤性脑损伤后，β受体阻滞剂对生存率的影响

2016-03-13

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

Thorax：长效β受体阻滞剂与长效毒蕈碱受体拮抗剂联合治疗COPD的疗效与安全分析

2016-08-04

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

Chest：治疗脓毒症期间房颤——β受体阻滞剂优于CCBs

2016-09-26

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

Sci Rep：终末期肾脏疾病患者可应用β受体阻滞剂预防房颤发生

2016-03-20

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

JAMA Intern Med：使用β受体阻滞剂降压治疗风险大

2016-07-16

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

BJA：β-受体阻滞剂对腹主动脉瘤病人体能的影响

2016-01-09

科室
- - 订阅+
  - 更多科室
工具
服务